Work

Evaluating ovarian function in infertile patients: the combined diagnostic utility of anti-müllerian hormone and angiopoietin-like protein 8

Year: 2025

Type: article

Abstract: BACKGROUND: This study aims to explore the value of anti-Müllerian hormone (AMH) in combination with angiopoietin-like protein 8 (ANGPTL8) in evaluating the ovarian function of infertile patients. METHODS: A total of 213 infertile patients who sought treatment in our hospital from January 2023 to July 2024 were included. Transvaginal color Doppler ultrasound assessed antral follicle count and ovarian reserve. Patients were divided into a0 control group (116 cases with normal ovarian reserve) and a research group (97 cases with decreased ovarian reserve). Serum levels of AMH, ANGPTL8, and sex hormones were measured for all patients, and results were compared between groups to analyze the combined assessment's value. RESULTS: In the control group, AMH levels were (4.44±2.36) ng/ml, ANGPTL8 (17.81±7.79) ng/ml, and estradiol (E2) (37.21±17.78) pg/ml. In the research group, AMH was (0.64±0.61) ng/ml, ANGPTL8 (12.04±5.04) ng/ml, and E2 (32.80±10.10) pg/ml. The research group showed significantly lower AMH, ANGPTL8, and E2 levels (P<0.05) and higher FSH and LH levels (P<0.001). The combined AMH and ANGPTL8 assessment demonstrated a sensitivity of 94.0%, specificity of 95.9%, and an area under the curve of 0.988. CONCLUSION: The combined assessment of AMH and ANGPTL8 holds significant value in evaluating ovarian function in infertile patients.

Source: Gynecological Endocrinology

DOI: 10.1080/09513590.2025.2530568